eIFU eligibility

Can your device go paperless? An eIFU decision tree

Six gates determine whether a device qualifies for electronic instructions for use in the EU. The tree, the article behind each gate, and the mixed-use cases.

Last reviewed

6
Gates
(EU) 2021/2226
Implementing Regulation
(EU) 2025/1234
As amended by
10 / 15 yr
Retention
Can this device go paperless?

Electronic instructions for use in the EU

Regulation (EU) 2021/2226 as amended by Regulation (EU) 2025/1234. Gates 1, 2, 3, 5 and 6 are pass or fail. Gate 4 determines which document remains on paper.

  1. Does the device need instructions for use at all?

    No

    No instructions are required, so there is nothing to publish. Class I and IIa devices usable safely without them are excepted (Annex I, 23.1(d) MDR).

    Yes

  2. Is it a device under the MDR?

    No

    In vitro diagnostics fall under the IVDR: professional use only, and excluded for near-patient testing (Annex I, 20.1(f) IVDR).

    Yes

  3. Is it intended for use by professional users?

    No

    Electronic instructions are permitted for professional-use devices only (Article 3(1)). A lay-user device keeps its paper instructions (MDR, Annex I, 23.1(d)). Software has a separate route (Article 3(3)).

    Yes

  4. Is use by lay persons reasonably foreseeable?

    Yes

    The instructions written for lay persons are provided on paper. The professional instructions may remain electronic (Article 3(2)).

    No

  5. Does your risk assessment show safety is maintained or improved?

    No

    Not established. The electronic form is not appropriate for this device until the assessment supports it (Articles 4 and 5(1)).

    Yes

  6. Can you hold the conditions for the full 10 or 15 years?

    No

    Retention, paper on request, language, label and website requirements apply for the whole period (Articles 5, 6 and 7).

    Yes

Electronic instructions for use are permitted for this device.

Separate route: software

MDR software may deliver its instructions through itself (Article 3(3)).

A paper copy remains available on request throughout the retention period (Article 5(3)).

The six gates

Each gate in the tree, the article it comes from, and what decides it.

  1. Gate 1

    Does the device need instructions for use at all?

    MDR, Annex I, Ch. III, 23.1(d)

    Instructions for use must in principle be supplied with a device. The MDR excepts class I and class IIa devices that can be used safely without them. The exception is narrow, and other provisions of that Section may still require information to be supplied with the device.

    This gate is first because it can remove part of a portfolio at no cost: where no instructions are required, there is nothing to publish.

    If no No instructions are required, so there is nothing to publish. Class I and IIa devices usable safely without them are excepted (Annex I, 23.1(d) MDR).

  2. Gate 2

    Is it a device under the MDR?

    MDR Art. 1(4) IVDR, Annex I, 20.1(f)

    “Device” means medical devices, accessories for medical devices, and the products listed in Annex XVI . Devices supplied under the Article 120 transitional provisions are covered too (recital 3 of 2025/1234).

    In vitro diagnostics fall outside this regulation. The IVDR carries its own permission, on similar but not identical terms.

    If no In vitro diagnostics fall under the IVDR: professional use only, and excluded for near-patient testing (Annex I, 20.1(f) IVDR).

  3. Gate 3

    Is it intended for use by professional users?

    Art. 3(1) definition at Art. 2(2)

    The term is defined: professional users are persons using the device in the course of their work in the framework of a professional healthcare activity. The question is therefore the capacity in which the device is handled, rather than the identity of the purchaser.

    If no Electronic instructions are permitted for professional-use devices only (Article 3(1)). A lay-user device keeps its paper instructions (MDR, Annex I, 23.1(d)). Software has a separate route (Article 3(3)).

  4. Gate 4

    Is use by lay persons reasonably foreseeable?

    Art. 3(2)

    The provision operates on the instructions rather than on the device, so foreseeable lay use no longer removes the device from scope.

    It only assists where the clinical document and the lay-facing document exist separately. Where a single instruction serves both audiences, there is nothing to separate, and the document is printed in full.

    The reasoning on mixed-use portfolios

    If yes The instructions written for lay persons are provided on paper. The professional instructions may remain electronic (Article 3(2)).

  5. Gate 5

    Does your risk assessment show safety is maintained or improved?

    Art. 4 Art. 5(1)

    Gates 1 to 4 establish that electronic instructions are permitted. They do not establish that the electronic form is appropriate for the device in question — that is what the documented risk assessment is for, and it is where an eligibility review does most of its work.

    It has to demonstrate that the electronic form maintains or improves the level of safety obtained on paper, and to cover at least the eleven elements listed at Article 4(1). Three of them tend to decide the answer for a given device.

    • The environment the device is used in What has to be described is the setting at the point of use, not the conditions the document was written in. A shared terminal in an operating theatre, a sterile field where nobody can touch a screen, an ambulance outside network coverage and a patient’s living room give four different answers for the same instruction — and where one device is used in several of them, the assessment is only as strong as the least favourable of them. Art. 4(1)(b)
    • Access to the resources needed at the time of use “At the time of use” is what makes this element bite. A document that is faultlessly available from an office desk can still be out of reach in the room where the device is opened, so what counts is the hardware the user can reasonably be expected to have to hand, the connection in that room, and anything standing in between — a login, an app, a file that will not open on the screen that is actually there. Art. 4(1)(d)
    • Foreseeable medical emergencies This element is not a judgement on the electronic system; it identifies the situations in which nobody will be looking anything up. Where the assessment finds one, that information goes on the device itself or on a leaflet with it ( Article 5(4) ) — which is a carve-out from the electronic route rather than a disqualification from it, since the rest of the instructions can still be electronic. Art. 4(1)(g)

    The assessment also fixes the period within which paper will be supplied on request ( Article 4(1)(i) ). That period is for the manufacturer to justify, and Article 5(3) caps it at 7 calendar days from the request — or delivery with the device, where the user asks at the time of order.

    If no Not established. The electronic form is not appropriate for this device until the assessment supports it (Articles 4 and 5(1)).

  6. Gate 6

    Can you hold the conditions for the full 10 or 15 years?

    Article 5 Article 6 Article 7

    The final gate is operational rather than legal. The conditions are not difficult to read; the question is whether they can be held for as long as the retention periods run.

    The 25 conditions, article by article
    Requirement Article
    Retention: 10 years after the last device is placed on the market, and at least 2 years after that expiry date Art. 5(9)
    15 years for implantable devices and for devices with no defined expiry date Art. 5(10)
    Paper on request, at no additional cost Art. 5(3)
    Availability in every Member State where the device is made available, in a language that Member State determines Art. 5(2) Art. 5(11)
    Version history for the retention periods, with obsolete versions available on request Art. 5(13)
    Label and access information, including the Basic UDI-DI or UDI-DI and how to obtain paper Art. 6
    A website meeting Article 7(2) , including an internet address that stays stable and directly accessible for the whole retention period Art. 7(2)(e)
    The address registered in the UDI database Art. 7(3)

    Article 7(2)(e) is the condition least likely to be satisfied by a document hosted on a general marketing website, because the address is fixed for the retention period rather than for the life of the current site.

    If no Retention, paper on request, language, label and website requirements apply for the whole period (Articles 5, 6 and 7).

The separate route for software

Where software is covered by the MDR, the manufacturer may provide the instructions through the software itself rather than on paper. The provision concerns the means of delivery, not the category of user.

Art. 3(3)

Electronic supplied alongside paper

Publishing electronic instructions while continuing to supply the printed leaflet is a different case, and the gates above do not apply to it. The requirement is consistency with the paper version — and maintaining that across languages and revisions is the part that takes work.

Art. 9

What the electronic form does not remove

Art. 5(3) Art. 5(9) Art. 5(10)

A paper copy on request

At no additional cost, for as long as the retention period runs.

Art. 5(4)

Emergency information

Information on foreseeable medical emergency situations, provided on the device or on a leaflet.

Art. 6(2)

Access information

On the packaging or, where that is not practicable, in a paper document supplied with each device.

Art. 6(5)

The full text

Electronic instructions must be complete as text, which may contain symbols and graphics. Video and audio may be added, never substituted.

Using this in practice

  1. Run it per device family

    Not once for the company. Gates 4, 5 and 6 can produce different results for products held under the same quality system.

  2. Record gates 3 and 4 as you go

    Both are positions that may have to be defended during conformity assessment, and both are easier to write down than to reconstruct.

  3. Resolve gate 6 before choosing a solution

    It concerns a commitment measured in years rather than a decision taken now.

Qualifying is not the same as being obliged. Regulation (EU) 2025/1234 permits electronic instructions for professional-use devices; it does not require them, and the paper-on-request duty is unaffected.

Sources

Every statement on this page is traceable to one of these texts, read in the Official Journal rather than in secondary commentary.

Show 4 sources
  • Commission Implementing Regulation (EU) 2021/2226 Article 2(2) definition of professional users. Article 3(1), (2) and (3) scope, lay persons and software. Article 4(1) risk assessment elements, including points (b), (d), (g) and (i). Article 5, points (1), (2), (3), (4), (9), (10), (11) and (13). Article 6, paragraphs (1), (2), (3) and (5). Article 7(2) website requirements. Article 9 electronic instructions provided in addition to paper.
  • Commission Implementing Regulation (EU) 2025/1234 Amending 2021/2226 as regards the medical devices for which the instructions for use may be provided in electronic form. Deletion of the third subparagraph of Article 1, which had excluded Annex XVI products; deletion of “medical” from Article 2, point (2), and replacement of point (3); replacement of Article 3(1) and 3(2); deletion of Article 5, point (12) and replacement of point (13); deletion of Article 6(4); deletion of Article 7(2), point (f), and the new Article 7(3) on the UDI database; deletion of Article 8; deletion of the second paragraph of Article 9. Recital 3: devices under the transitional provisions of Article 120.
  • Regulation (EU) 2017/745 (MDR) Article 1(4), and Annex I, Chapter III, Section 23.1, points (d) and (f).
  • Regulation (EU) 2017/746 (IVDR) Annex I, Chapter III, Section 20.1(f).